Related Experiment Video
Updated: May 13, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Impact of fibrosis on response to interferon therapy in Egyptian HCV patients
Eman H Abdel-Bary1, Amal M Mangoud, Hoda A El-Hady
1Department of Pathology, Faculty of Medicine, Zagazig University, Egypt.
Abstract:
Hepatitis C virus (HCV) infection is a global health problem which can lead to liver cirrhosis or hepatocellular carcinoma in one-fifth of chronically infected patients. HCV-4 infection is common in the Middle East and Africa, with an extraordinary high prevalence in Egypt. Interferon is a cytokine, a specific protein that is no stranger to the human body. In fact, the human body is constantly making interferon, and makes even greater amounts when trying to fight off an intruder, such as a virus. This work studied the impact of liver fibrosis on the efficacy of interferon in treating HCV.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatitis
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
